Alnylam Pharmaceuticals Inc
SWB:DUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alnylam Pharmaceuticals Inc
SWB:DUL
|
US |
|
E
|
Entergy Corp
DUS:ETY
|
US |
|
N
|
National Grid PLC
DUS:NNGF
|
UK |
|
DSV A/S
F:DS81
|
DK |
|
A
|
Amkor Technology Inc
F:AMK
|
US |
|
T
|
TC Energy Corp
SWB:TRS
|
CA |
|
C
|
China Mobile Ltd
XMUN:CTM
|
CN |
|
A
|
Air Products and Chemicals Inc
SWB:AP3
|
US |
|
F
|
First Majestic Silver Corp
SWB:FMV
|
CA |
|
OUTsurance Group Ltd
OTC:RMRHF
|
ZA |
|
A
|
Ameriprise Financial Inc
F:A4S
|
US |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
H
|
Hecla Mining Co
F:HCL
|
US |
|
S
|
Sanrio Co Ltd
SWB:SJ8
|
JP |
Wall St Price Targets
DUL Price Targets Summary
Alnylam Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for DUL is 382.91 EUR with a low forecast of 200.71 EUR and a high forecast of 500.43 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DUL's stock price target?
Price Target
382.91
EUR
According to Wall Street analysts, the average 1-year price target for DUL is 382.91 EUR with a low forecast of 200.71 EUR and a high forecast of 500.43 EUR.
What is the Revenue forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 17%.
What is the Operating Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 8 years is 36%.
What is the Net Income forecast for Alnylam Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Net Income over the next 8 years is 41%.
